Clinical Trial Update: Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pomalidomide-cyclophosphamide-dexamethasone (PCD) versus pomalidomide-dexamethasone (PD) in relapse or refractory multiple myeloma; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Pomalyst (pomalidomide)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Relapse Multiple Myeloma | Phase 3 | Status: UNKNOWN